Julie Earl

Biography and Career

Julie Earl, PhD in molecular biology from the University of Liverpool, UK (2003). Principal investigator in the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS). Her main focus of research is the genetics of pancreatic cancer and the identification of germline variants that increase pancreatic cancer risk, as well as the identification and validation of biomarkers for early detection. Corresponding author on publications addressing pre-analytical standards in liquid biopsy, circulating biomarkers for the early detection of pancreatic cancer, and treatment-response monitoring. She has secured funding for ongoing industrial and international projects focused on biomarker research for the early detection of pancreatic cancer and is the PI and scientific lead on competitive private and intramural translational research grants, including funding to support a PhD student and a technician, and has supervised three PhD students who successfully defended their theses. She has published 66 articles (60 indexed in Web of Science), including 13 as corresponding author, with a cumulative impact factor of 644, over 2,061 citations, and an H-index of 23.